跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler - TGA Drug Approval Details
Approvals
/
TGA
/
FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Approved
STANDARD
FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
60f7b5ec9e152d7e
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
60f7b5ec9e152d7e
Product Name
FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Artg Id
331741
Artg Name
FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2021-08-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8c84a2a650b7b3ee3d548a1678a3bc5a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7044d18084ef9e8989b37fa1384f4ebf.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
60f7b5ec9e152d7e
Type
Standard
Back to TGA Approvals